These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 12067982)

  • 41. Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis.
    Weeks BH; He W; Olson KL; Wang XJ
    Cancer Res; 2001 Oct; 61(20):7435-43. PubMed ID: 11606377
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EGFR overexpression induces activation of telomerase via PI3K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesis.
    Heeg S; Hirt N; Queisser A; Schmieg H; Thaler M; Kunert H; Quante M; Goessel G; von Werder A; Harder J; Beijersbergen R; Blum HE; Nakagawa H; Opitz OG
    Cancer Sci; 2011 Feb; 102(2):351-60. PubMed ID: 21156006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling.
    Wells A; Souto JC; Solava J; Kassis J; Bailey KJ; Turner T
    Clin Cancer Res; 2002 Apr; 8(4):1251-7. PubMed ID: 11948140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells.
    Mueller MM; Fusenig NE
    Differentiation; 2002 Dec; 70(9-10):486-97. PubMed ID: 12492491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
    Bowden GT; Schneider B; Domann R; Kulesz-Martin M
    Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
    Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR
    Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
    Tokumitsu Y; Nakano S; Ueno H; Niho Y
    J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor.
    Lammering G; Valerie K; Lin PS; Mikkelsen RB; Contessa JN; Feden JP; Farnsworth J; Dent P; Schmidt-Ullrich RK
    Clin Cancer Res; 2001 Mar; 7(3):682-90. PubMed ID: 11297265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ha-ras and v-raf oncogenes, but not int-2 and c-myc, interfere with the lactogenic hormone dependent activation of the mammary gland specific transcription factor.
    Happ B; Hynes NE; Groner B
    Cell Growth Differ; 1993 Jan; 4(1):9-15. PubMed ID: 8424907
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kinase-deficient neu proteins suppress epidermal growth factor receptor function and abolish cell transformation.
    Qian X; Dougall WC; Hellman ME; Greene MI
    Oncogene; 1994 May; 9(5):1507-14. PubMed ID: 7908733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
    Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
    Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibroblast growth factors are required for efficient tumor angiogenesis.
    Compagni A; Wilgenbus P; Impagnatiello MA; Cotten M; Christofori G
    Cancer Res; 2000 Dec; 60(24):7163-9. PubMed ID: 11156426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of retinoic acid receptors in mouse skin and skin tumors is associated with activation of the ras(Ha) oncogene and high risk for premalignant progression.
    Darwiche N; Scita G; Jones C; Rutberg S; Greenwald E; Tennenbaum T; Collins SJ; De Luca LM; Yuspa SH
    Cancer Res; 1996 Nov; 56(21):4942-9. PubMed ID: 8895748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased incidence of papillomas in mice with impaired EGFR function during multi-stage skin carcinogenesis.
    Dahlhoff M; Rose C; Wolf E; Schneider MR
    Exp Dermatol; 2011 Mar; 20(3):290-3. PubMed ID: 21323750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-rasHa oncogene.
    Weinberg WC; Azzoli CG; Kadiwar N; Yuspa SH
    Cancer Res; 1994 Nov; 54(21):5584-92. PubMed ID: 7923201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased expression of mutated Ha-ras during premalignant progression in SENCAR mouse skin.
    Rodriguez-Puebla ML; LaCava M; Bolontrade MF; Russell J; Conti CJ
    Mol Carcinog; 1999 Nov; 26(3):150-6. PubMed ID: 10559789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular mechanisms of malignant conversion in skin carcinogenesis.
    Yuspa SH; Greenhalgh DA
    Princess Takamatsu Symp; 1989; 20():281-8. PubMed ID: 2518687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The up-regulation of vascular endothelial growth factor in mutated Ha-ras HaCaT cell lines is reduced by a farnesyl transferase inhibitor.
    Charvat S; Duchesne M; Parvaz P; Chignol MC; Schmitt D; Serres M
    Anticancer Res; 1999; 19(1A):557-61. PubMed ID: 10226598
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line.
    Ma L; Gauvillé C; Berthois Y; Millot G; Johnson GR; Calvo F
    Oncogene; 1999 Nov; 18(47):6513-20. PubMed ID: 10597254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of growth control by TGF-beta occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation.
    Haddow S; Fowlis DJ; Parkinson K; Akhurst RJ; Balmain A
    Oncogene; 1991 Aug; 6(8):1465-70. PubMed ID: 1886717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.